Back to search

Article

A silk-based platform to stabilize phenylalanine ammonia-lyase (PAL) for orally administered enzyme replacement therapy

2022-04-14

Abstract excerpt

<h4>ABSTRACT</h4> Phenylalanine ammonia-lyase (PAL) has gained attention in recent years for the treatment of phenylketonuria (PKU), a genetic disorder that affects ∼1 in 15,000 individuals globally. However, the enzyme is easily degraded by proteases, unstable at room temperature, and is currently administered in PKU patients as daily subcutaneous injections. We report here the stabilization of the PAL from Ana...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
930a1e0e-e13b-59cd-bb4e-59ae912b75a7
DOI
10.1101/2022.04.14.488340
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A silk-based platform to stabilize phenylalanine ammonia-lyase (PAL) for orally administered enzyme replacement therapyDOI 10.1101/2022.04.14.488340
Select a neighboring publication to make it the new centre.